Safety and Bioavailability of IV and SC LBR-101

Study Title
Safety and Bioavailability of IV and SC LBR-101
Teva Identifier
LBR-101-011
ClinicalTrials.gov Identifier
NCT01991509
Study Status
Completed
Trial Condition(s)
Bioavailability and Pharmacokinetics
Interventions
Biological: LBR-101 IV | Biological: LBR-101 SC
Study Description
Please refer to ClinicalTrials.gov for a description of the trial
Print

Participation criteria and map of study locations
disease-icon

Key Participation Requirements

Gender
Female, Male
Age group
Adult
Age Range
18 Years to 60 Years
Trial Duration
10/01/2013 - 01/01/2015
Phase
Phase 1

Study Type

Interventional